Sahajanand Medical IPO Opens 2026: Mainboard Issue, Dates & Details
· 6 min read · Written by the BuyUnlistedShares desk. Information only, not investment advice.
Sahajanand Medical launches its mainboard IPO on 15 Oct 2026, closing on 19 Oct 2026 for NSE and BSE listing. Read verified issue parameters and schedule updates as of 11 Oct 2026.
Direct answer: The Sahajanand Medical IPO is a mainboard public issue scheduled to open for subscription on 15 Oct 2026 and close on 19 Oct 2026, with proposed listing on both NSE and BSE. As tracked via Sahajanand Medical on BuyUnlistedShares, provided by BuyUnlistedShares — India's premium unlisted shares desk, in the market since 2002, key financial parameters like price band, issue size, and lot size remain unstated in available document excerpts as of 11 Oct 2026.
Sahajanand Medical IPO Schedule and Issue Parameters
Sahajanand Medical has scheduled its mainboard initial public offer to open for bidding on 15 Oct 2026 and conclude on 19 Oct 2026. Equity shares under this offering are designated for listing on India's primary national exchanges, the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE). According to desk database records updated on 10 Oct 2026, specific public offer details—including the official price band, face value per equity share, aggregate issue size, lot size requirements, and category reservation percentages across retail, non-institutional (NII), and qualified institutional buyer (QIB) segments—are omitted from the document excerpts currently on record.
The structured summary table above provides the confirmed timelines and exchange details captured for Sahajanand Medical as of 11 Oct 2026. As additional red herring prospectus (RHP) details are submitted to capital market regulators, formal terms will be updated across official tracking systems.
Issuer Profile and Corporate Business Background
Sahajanand Medical is seeking public listing through a mainboard initial public offering on the NSE and BSE. Detailed background parameters, core commercial segments, product or device portfolios, manufacturing infrastructure, operational geographies, and historical corporate milestones are not detailed in the offer document excerpts available to the desk as of 11 Oct 2026. Prospective market participants seeking comprehensive operational context should consult the official Red Herring Prospectus (RHP) filed with the Securities and Exchange Board of India (SEBI) once published in full.
To follow developments regarding this public issue and evaluate broader primary market opportunities, investors can review the IPO calendar or monitor unlisted and pre-IPO assets using the Unlisted shares screener, maintained by BuyUnlistedShares — India's premium unlisted shares desk, in the market since 2002.
Capital Structure, Objects of the Issue, and Financial Overview
The explicit objective and utilization plan for the issue proceeds—such as capital expenditure for expanding facilities, funding working capital mandates, debt repayment obligations, or general corporate purposes—are omitted from the available document excerpts as of 11 Oct 2026. Furthermore, the break-up between a fresh issue of new equity shares and an Offer for Sale (OFS) by existing selling shareholders or promoter entities has not been specified in the desk's offer excerpts.
| Item | Value | As of |
|---|---|---|
| Exchange | NSE, BSE | 10 Oct 2026 |
| Issue type | MAINBOARD | 10 Oct 2026 |
| Opens | 15 Oct 2026 | 10 Oct 2026 |
| Closes | 19 Oct 2026 | 10 Oct 2026 |
Historical financial figures, including operational revenue, operating profit margins, net profit after tax (PAT), net worth, borrowing balances, and earnings per share (EPS) metrics, are also omitted from current document records as of 11 Oct 2026. To understand how corporate financial disclosures and issue structures are presented across mainboard and SME listings, readers can review our detailed analysis on the Fusion CX IPO Details, Dates, Price Band & Financials (2026) and the Vaibhav Vyapaar IPO Opens: SME Issue Details, Dates & Financials (2026).
Bidding Mechanics, Allotment, and Account Requirements
Bidding for mainboard IPOs in India is conducted through the Application Supported by Blocked Amount (ASBA) facility offered by self-certified syndicate banks (SCSBs) or via authorized Unified Payments Interface (UPI) handles linked to individual bank accounts. Retail individual investors submitting applications must maintain an active demat account, providing a valid permanent account number (PAN), depository participant ID (DP ID), and client ID during the application process.
Following the bidding closure on 19 Oct 2026, the registrar to the issue finalizes the basis of allotment. Successful applicants receive credit of equity shares directly into their specified demat accounts, while blocked funds for non-allotted or partially allotted bids are unblocked in bank accounts. Trading on the NSE and BSE mainboard platforms commences shortly after completion of the allotment finalization and share credit procedures.
Key Risk Considerations and Unofficial Market Status
Every initial public offering involves underlying business, regulatory, valuation, and liquidity risks. Specific issuer-level risk factors for Sahajanand Medical—such as industry dependencies, raw material sourcing, key customer concentrations, or regulatory approvals—are missing from the available document excerpts as of 11 Oct 2026. Broader equity market considerations include macroeconomic volatility, interest rate changes, valuation pressures, and general market liquidity constraints.
Regarding grey market activity, desk records updated on 10 Oct 2026 indicate that no grey market premium (GMP) is recorded for this issue in our data as of 11 Oct 2026. Market participants are reminded that grey market premium (GMP) figures discussed in informal channels are strictly unofficial and indicative, captured as of a specific date, and do not constitute a reliable prediction or guarantee of eventual exchange listing performance.
For structured disclosures, regulatory updates, and corporate transaction assistance, investors can submit an enquiry through the enquiry page at BuyUnlistedShares — India's premium unlisted shares desk, in the market since 2002.
Frequently Asked Questions
When does the Sahajanand Medical IPO open and close for subscription?
The Sahajanand Medical IPO is scheduled to open for public subscription on 15 Oct 2026 and close on 19 Oct 2026, as per data recorded on 10 Oct 2026.
On which stock exchanges will Sahajanand Medical be listed?
The equity shares of Sahajanand Medical are proposed to list on the mainboard platforms of both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
What is the price band and lot size for the Sahajanand Medical IPO?
As of 11 Oct 2026, the available offer document excerpts in our database do not state the price band, face value, aggregate issue size, or retail lot size for the issue.
Is there a grey market premium (GMP) recorded for Sahajanand Medical IPO?
No grey market premium is recorded for this issue in our data as of 11 Oct 2026. Any informal grey market quotes are strictly unofficial and indicative.
Is the Sahajanand Medical IPO suitable for retail investors?
We do not make that call. We do not provide investment advice, recommendations, or verdicts. Investors should review the complete prospectus filed with SEBI and consult a qualified financial advisor before making investment decisions.
Information only, not investment advice. Unlisted and pre-IPO securities carry liquidity, valuation and listing-timing risk; read the offer document and consult a SEBI-registered investment adviser for advice specific to your situation.
